Treatment of Malignant Endocrine Pancreatic Tumors with a Combination of α-Interferon and Somatostatin Analogs
- 1 January 2002
- journal article
- Published by Springer Nature in Medical Oncology
- Vol. 19 (1) , 35-42
- https://doi.org/10.1385/mo:19:1:35
Abstract
Somatostatin analogs and α-interferon induce good responses as single drugs in the treatment of endocrine pancreatic tumors. We examined the efficacy and tolerability of the combination of...Keywords
This publication has 19 references indexed in Scilit:
- Combination Therapy With Octreotide and α-Interferon:American Journal of Gastroenterology, 1999
- Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.1992
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumorsCancer, 1990
- Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumorsDigestive Diseases and Sciences, 1989
- Islet Cell Tumors Metastatic to the Liver: Effective Palliation by Sequential Hepatic Artery EmbolizationAnnals of Internal Medicine, 1988
- TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERONThe Lancet, 1986
- Apudomas metastatic to the liver: treatment by hepatic artery embolization.Radiology, 1983
- Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1980
- Effect of Long‐Term Treatment with Human Leukocyte Interferon on Various Laboratory ParametersActa Medica Scandinavica, 1980